C. Marban

发表

Identification of Morphine-6-glucuronide in Chromaffin Cell Secretory Granules*

Arnaud H. Muller, D. Aunis, S. Chasserot-Golaz, 2006, Journal of Biological Chemistry.

CTIP2 is a negative regulator of P-TEFb

F. Dequiedt, C. Van Lint, X. Graña, 2013, Proceedings of the National Academy of Sciences.

HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1

C. Van Lint, F. Forouzanfar, Sebastian Eilebrecht, 2016, Scientific Reports.

On the way to find a cure: Purging latent HIV‐1 reservoirs

C. Van Lint, C. Schwartz, S. Bouchat, 2017, Biochemical Pharmacology.

HIV-1 regulation of latency in the monocyte-macrophage lineage and in CD4 (cid:1) T lymphocytes

D. Aunis, C. Schwartz, O. Rohr, 2010 .

In Trauma Patients, the Occurrence of Early-Onset Nosocomial Infections is Associated With Increased Plasma Concentrations of Chromogranin A

O. Rohr, M. Guillot, F. Schneider, 2017, Shock.

A New Combination with D-Cateslytin to Eradicate Root Canal Pathogens

C. Marban, M. Metz-Boutigue, Yoshihito Kurashige, 2019, International Journal of Peptide Research and Therapeutics.

Interplay between the HTLV-2 Tax and APH-2 proteins in the regulation of the AP-1 pathway

W. Hall, C. Marban, N. Sheehy, 2012, Retrovirology.

Cateslytin, a Chromogranin A Derived Peptide Is Active against Staphylococcus aureus and Resistant to Degradation by Its Proteases

F. Delalande, A. van Dorsselaer, R. Aslam, 2013, PloS one.

Activation of neutrophils by the two-component leukotoxin LukE/D from Staphylococcus aureus: proteomic analysis of the secretions.

R. Aslam, J. Strub, Y. Haikel, 2013, Journal of proteome research.

COUP-TF interacting protein 2 represses the initial phase of HIV-1 gene transcription in human microglial cells

C. Van Lint, D. Aunis, S. Chasserot-Golaz, 2005, Nucleic acids research.

Regulation of HIV‐1 gene transcription: from lymphocytes to microglial cells

D. Aunis, O. Rohr, C. Marban, 2003, Journal of leukocyte biology.

p21WAF1 gene promoter is epigenetically silenced by CTIP2 and SUV39H1

D. Aunis, C. Schwartz, S. Zeichner, 2009, Oncogene.

D-Cateslytin: a new antifungal agent for the treatment of oral Candida albicans associated infections

S. Cianférani, J. Strub, C. Boehler, 2018, Scientific Reports.

Targeting the Brain Reservoirs: Toward an HIV Cure

F. Forouzanfar, C. Schwartz, O. Rohr, 2016, Front. Immunol..

Genome-Wide Binding Map of the HIV-1 Tat Protein to the Human Genome

M. Pellegrini, R. Ferrari, J. Zack, 2011, PloS one.

HIV‐1 regulation of latency in the monocyte‐macrophage lineage and in CD4+ T lymphocytes

C. Van Lint, D. Aunis, C. Schwartz, 2010, Journal of leukocyte biology.

Recruitment of chromatin‐modifying enzymes by CTIP2 promotes HIV‐1 transcriptional silencing

F. Dequiedt, C. Van Lint, D. Aunis, 2007, The EMBO journal.

Recruitment of Tat to Heterochromatin Protein HP1 via Interaction with CTIP2 Inhibits Human Immunodeficiency Virus Type 1 Replication in Microglial Cells

D. Aunis, S. Chasserot-Golaz, M. Leid, 2003, Journal of Virology.

Chromofungin, CgA47-66-derived peptide, produces basal cardiac effects and postconditioning cardioprotective action during ischemia/reperfusion injury

N. Amodio, F. Schneider, C. Marban, 2015, Peptides.

Improving combination antiretroviral therapy by targeting HIV-1 gene transcription

C. Schwartz, O. Rohr, C. Marban, 2016, Expert opinion on therapeutic targets.

gene promoter is epigenetically silenced by CTIP 2 and SUV 39 H 1

D. Aunis, C. Schwartz, O. Rohr, 2012 .

Repression of Human T-lymphotropic virus type 1 Long Terminal Repeat sense transcription by Sp1 recruitment to novel Sp1 binding sites

A. Burny, C. Van Lint, A. Kula, 2017, Scientific Reports.

D-Cateslytin, a new antimicrobial peptide with therapeutic potential

P. Lavalle, B. Frisch, C. Boehler, 2017, Scientific Reports.

Cross-company evaluation of the human lymphocyte activation assay

J. Lebrón, C. Marban, A. Langenkamp, 2020, Journal of immunotoxicology.